InspireMD, Inc. (NSPR) Stock Price, Financials & Summary

Price chart

Aug 19Aug 24Aug 27Sep 1Sep 4Sep 10Sep 15Sep 18

Key dataSep 18, 2026

Open$0.76

From 52W high−69.30%

Volume19831.00

Market cap$35.68M

P/E (TTM)—

P/S (TTM)3.3x

Div yield—

Key dataSep 18, 2026

Open

$0.76

From 52W high

−69.30%

Volume

19831.00

Market cap

$35.68M

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−0.2x

P/E (TTM)

—

RSI (14)

47.1

MomentumView details →

1D Return

+1.37%

YTD Return

−55.34%

SummaryUpdated Jun 1, 2026

InspireMD, Inc. (NASDAQ:NSPR) is an Israeli medical device company founded in 2005 and headquartered in Tel Aviv-Yafo, Israel. The company specializes in developing and commercializing proprietary MicroNet stent platform technology for treating vascular and coronary diseases. InspireMD has been publicly traded since 2011 and operates primarily in international markets including Europe, Latin America, the Middle East, and Asia Pacific through local distributors. The company is currently preparing for its most significant milestone - entering the U.S. market with FDA approval expected for its flagship CGuard Prime system in 2025.

Ask drillr about InspireMD, Inc. →

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

—

EV/EBITDA

−0.2x

EV/Sales

0.7x

P/S (TTM)

3.3x

P/B (TTM)

1.1x

ProfitabilityView details →

Gross Margin

18.05%

Net Margin

−355.17%

EBITDA Margin

−349.45%

ROE (TTM)

−122.19%

ROA (TTM)

−86.25%

Asset Turnover

0.21x

GrowthView details →

Revenue YoY

+53.42%

EPS YoY

+40.23%

FCF YoY

−35.91%

Revenue CAGR 3Y

+20.19%

EPS CAGR 3Y

+0.00%

EBITDA YoY

+9.07%

MomentumView details →

1D Return

+1.37%

YTD Return

−55.34%

1Y Return

−67.56%

RSI (14)

47.1

vs 50D SMA

+0.96%

vs 200D SMA

−37.43%

Capital & dividendView details →

Debt/Equity

0.06x

Current Ratio

3.80x

Quick Ratio

3.52x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

−$0.17

EPS Surprise

15.00%

Beats (12Q)

8/12

Next Q EPS Est

−$0.15

Avg Surprise (4Q)

7.24%

Rev Surprise

28.05%

Financials snapshotView financials →

Revenue (TTM)

10.84M

Net Income (TTM)

−38.50M

Op. CF (TTM)

−41.21M

Next earningsNov 10, 2026 →

Latest newsMore news →

InspireMD, Inc. reported a Q2 2026 net loss of $0.17 per share, beating the Zacks Consensus Estimate of a $0.20 loss and improving from a $0.26 loss a year earlier.37d ago

InspireMD granted 91,161 shares of restricted stock to six new non-executive employees as inducement grants on June 12, 2026.100d ago

Similar companies

QT Imaging Holdings, Inc.QTI PAVmed Inc.PAVM SANUWAVE Health, Inc.SNWV Baird Medical Investment Holdings LimitedBDMD Accuray IncorporatedARAY Inspira Technologies Oxy B.H.N. Ltd.IINN Find similar companies →

Latest newsMore news →

InspireMD, Inc. reported a Q2 2026 net loss of $0.17 per share, beating the Zacks Consensus Estimate of a $0.20 loss and improving from a $0.26 loss a year earlier.37d ago InspireMD granted 91,161 shares of restricted stock to six new non-executive employees as inducement grants on June 12, 2026.100d ago